MUC1 (CD227): a multi-tasked molecule

被引:117
作者
Apostolopoulos, Vasso [1 ]
Stojanovska, Lily [1 ]
Gargosky, Sharron E. [2 ]
机构
[1] Victoria Univ, Coll Hlth & Biomed, Ctr Chron Dis, Melbourne, Vic 8001, Australia
[2] Prima BioMed Ltd, Sydney, NSW, Australia
关键词
MUC1; CD227; PEM; EMA; isoforms; expression; structure; MUC1 and disease; MUC1 and pathogens; MUC1 and cancer; MEMBRANE-ASSOCIATED MUCINS; TUMOR-ANTIGEN MUC1; HUMAN T-CELLS; CARCINOMA-ASSOCIATED ANTIGEN; MULTIPLE-MYELOMA CELLS; LUNG EPITHELIAL-CELLS; FAT GLOBULE-MEMBRANE; BREAST-CANCER; MONOCLONAL-ANTIBODIES; GENE-EXPRESSION;
D O I
10.1007/s00018-015-2014-z
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
Mucin 1 (MUC1 [CD227]) is a high-molecular weight (> 400 kDa), type I membrane-tethered glycoprotein that is expressed on epithelial cells and extends far above the glycocalyx. MUC1 is overexpressed and aberrantly glycosylated in adenocarcinomas and in hematological malignancies. As a result, MUC1 has been a target for tumor immunotherapeutic studies in mice and in humans. MUC1 has been shown to have anti-adhesive and immunosuppressive properties, protects against infections, and is involved in the oncogenic process as well as in cell signaling. In addition, MUC1 plays a key role in the reproductive tract, in the immune system (affecting dendritic cells, monocytes, T cells, and B cells), and in chronic inflammatory diseases. Evidence for all of these roles for MUC1 is discussed herein and demonstrates that MUC1 is truly a multitasked molecule.
引用
收藏
页码:4475 / 4500
页数:26
相关论文
共 244 条
[1]
MUC1 mucin-mediated regulation of human T cells [J].
Agrawal, B ;
Longenecker, BM .
INTERNATIONAL IMMUNOLOGY, 2005, 17 (04) :391-399
[2]
Agrawal B, 1998, CANCER RES, V58, P4079
[3]
Endometrial Receptivity Defects and Impaired Implantation in Diabetic NOD Mice [J].
Albaghdadi, Ahmad J. H. ;
Kan, Frederick W. K. .
BIOLOGY OF REPRODUCTION, 2012, 87 (02)
[4]
Ando Iwao, 1998, Journal of Dermatology (Tokyo), V25, P150
[5]
Aplin JD, 2001, BIOCHEM SOC T, V29, P153, DOI 10.1042/0300-5127:0290153
[6]
CELLULAR MUCINS - TARGETS FOR IMMUNOTHERAPY [J].
APOSTOLOPOULOS, V ;
MCKENZIE, IFC .
CRITICAL REVIEWS IN IMMUNOLOGY, 1994, 14 (3-4) :293-309
[7]
PRODUCTION OF ANTI-BREAST CANCER MONOCLONAL-ANTIBODIES USING A GLUTATHIONE-S-TRANSFERASE-MUC1 BACTERIAL FUSION PROTEIN [J].
APOSTOLOPOULOS, V ;
XING, PX ;
TRAPANI, JA ;
MCKENZIE, IFC .
BRITISH JOURNAL OF CANCER, 1993, 67 (04) :713-720
[8]
OXIDATIVE REDUCTIVE CONJUGATION OF MANNAN TO ANTIGEN SELECTS FOR T-1 OR T-2 IMMUNE-RESPONSES [J].
APOSTOLOPOULOS, V ;
PIETERSZ, GA ;
LOVELAND, BE ;
SANDRIN, MS ;
MCKENZIE, IFC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (22) :10128-10132
[9]
Apostolopoulos V, 1997, J IMMUNOL, V159, P5211
[10]
THE IMMUNOGENICITY OF MUC1 PEPTIDES AND FUSION PROTEIN [J].
APOSTOLOPOULOS, V ;
PIETERSZ, GA ;
XING, PX ;
LEES, CJ ;
MICHAEL, M ;
BISHOP, J ;
MCKENZIE, IFC .
CANCER LETTERS, 1995, 90 (01) :21-26